5 Best Buy-the-Dip Stocks To Buy Right Now

3. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 81

Industry: Healthcare

Johnson & Johnson (NYSE:JNJ) is a global healthcare company that researches, develops, manufactures, and sells healthcare products worldwide. On January 5, Johnson & Johnson (NYSE:JNJ) declared a $1.19 per share quarterly dividend, in line with previous. The dividend is distributable on March 5, to shareholders of record on February 20. Johnson & Johnson (NYSE:JNJ) is one of the best 52-week low stocks to watch. 

According to Insider Monkey’s third quarter database, 81 hedge funds were long Johnson & Johnson (NYSE:JNJ), compared to 84 funds in the preceding quarter. Ken Fisher’s Fisher Asset Management is the largest stakeholder of the company, with 6.36 million shares worth $997 million. 

ClearBridge Large Cap Value Strategy made the following comment about Johnson & Johnson (NYSE:JNJ) in its Q3 2023 investor letter:

“The healthcare space provided some opportunities in the quarter, as we increased our exposure to medical device company Becton, Dickinson as well as large cap pharmaceutical company Johnson & Johnson (NYSE:JNJ). Johnson & Johnson recently spun out its consumer health care business, becoming a more focused yet broadly diversified pharmaceutical and medtech company.”

Follow Johnson & Johnson (NYSE:JNJ)